Search research articles

ABOUT JoVE

Overview Leadership Blog JoVE Help Center

AUTHORS

Publishing Process Editorial Board Scope & Policies Peer Review FAQ Submit

LIBRARIANS

Testimonials Subscriptions Access Resources Library Advisory Board FAQ

RESEARCH

JoVE Journal Methods Collections JoVE Encyclopedia of Experiments Archive

EDUCATION

JoVE Core JoVE Business JoVE Science Education JoVE Lab Manual Faculty Resource Center Faculty Site

Terms & Conditions of Use

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by

Same author

HER2∆16 directs luminal cell identity and estrogen receptor signaling in HER2+ breast cancer.

Nature communications·2026

Same author

Genome-wide CRISPR knockout cell screening platform for the disease vector tick species <i>Ixodes scapularis</i>.

bioRxiv : the preprint server for biology·2026

Same author

Intersecting experimental evolution and CRISPR screens to identify novel toxin resistance loci.

bioRxiv : the preprint server for biology·2026

Same author

DIOPT: the DRSC Integrative Ortholog Prediction Tool, 2026 update.

bioRxiv : the preprint server for biology·2026

Same author

Anti-Epstein-Barr virus (EBV) antibodies in EBV-associated gastric carcinoma.

Infectious agents and cancer·2026

Same author

Activating mutations in ESR1 contribute to an immunosuppressive breast tumor microenvironment by dampening cytokine secretion.

JCI insight·2026

Search research articles

Related Experiment Video

Updated: Jul 14, 2026

A High-throughput Automated Platform for the Development of Manufacturing Cell Lines for Protein Therapeutics

A High-throughput Automated Platform for the Development of Manufacturing Cell Lines for Protein Therapeutics

Published on: September 22, 2011

A novel approach to sequence validating protein expression clones with automated decision making.

Elena Taycher¹, Andreas Rolfs, Yanhui Hu

¹Harvard Institute of Proteomics, Harvard Medical School, Cambridge, MA 02141, USA. elena_taycher@hms.harvard.edu <elena_taycher@hms.harvard.edu>

BMC Bioinformatics

|June 15, 2007

Summary

Automated Clone Evaluation (ACE) software streamlines plasmid DNA sequence verification, significantly reducing time and improving accuracy compared to manual methods for high-throughput projects.

More Related Videos

Automated Robotic Liquid Handling Assembly of Modular DNA Devices

Automated Robotic Liquid Handling Assembly of Modular DNA Devices

Published on: December 1, 2017

Efficient Sampling of Genetically Encoded Biosensor Design Space Enabled with a Design of Experiments and Automation Workflow

Efficient Sampling of Genetically Encoded Biosensor Design Space Enabled with a Design of Experiments and Automation Workflow

Published on: October 17, 2025

Related Experiment Videos

Last Updated: Jul 14, 2026

A High-throughput Automated Platform for the Development of Manufacturing Cell Lines for Protein Therapeutics

A High-throughput Automated Platform for the Development of Manufacturing Cell Lines for Protein Therapeutics

Published on: September 22, 2011

Automated Robotic Liquid Handling Assembly of Modular DNA Devices

Automated Robotic Liquid Handling Assembly of Modular DNA Devices

Published on: December 1, 2017

Efficient Sampling of Genetically Encoded Biosensor Design Space Enabled with a Design of Experiments and Automation Workflow

Efficient Sampling of Genetically Encoded Biosensor Design Space Enabled with a Design of Experiments and Automation Workflow

Published on: October 17, 2025

Area of Science:

Molecular Biology
Bioinformatics
Genomics

Background:

Manual plasmid clone sequence verification is a bottleneck in high-throughput protein expression.
The increasing volume of unverified clones necessitates automated validation solutions.
Ensuring sequence accuracy is critical for successful downstream experimental applications.

Purpose of the Study:

To develop and evaluate an automated software system for rapid and accurate plasmid clone sequence verification.
To address the demand for efficient validation of large numbers of DNA clones.

Main Methods:

Developed the Automated Clone Evaluation (ACE) system, a web-based software package.
ACE defines clone sequences as discrepancy objects, comparing them against user-defined acceptance criteria.
The system manages contig assembly, discrepancy annotation, polymorphism identification, and clone finishing.

Main Results:

ACE provides a comprehensive, multi-platform solution for automated plasmid sequence verification.
Automated analysis by ACE was faster and more accurate than manual analysis in a comparative study.
The system successfully evaluated over 55,000 clones, demonstrating scalability and efficiency.

Conclusions:

ACE significantly reduces the time and labor required for high-throughput clone sequence validation.
The software improves accuracy by minimizing missed sequence discrepancies common in manual evaluations.
ACE optimizes sequencing efforts by reducing the number of reads needed for clone decision-making.